OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines

To prevent SARS-CoV-2 infections and generate long-lasting immunity, vaccines need to generate strong viral-specific B and T cell responses. Previous results from our lab and others have shown that immunizations in the presence of an OX40 agonist antibody lead to higher antibody titers and increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Duhen, Rebekka, Beymer, Michael, Jensen, Shawn M., Abbina, Srinivas, Abraham, Suraj, Jain, Nikita, Thomas, Anitha, Geall, Andrew J., Hu, Hong-Ming, Fox, Bernard A., Weinberg, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551348/
https://www.ncbi.nlm.nih.gov/pubmed/36238275
http://dx.doi.org/10.3389/fimmu.2022.896310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551348/
https://www.ncbi.nlm.nih.gov/pubmed/36238275
http://dx.doi.org/10.3389/fimmu.2022.896310

Ejemplares similares